World News

Concurrent Chemoradiotherapy Followed by Adjuvant Cisplatin-Gemcitabine for the Treatment of Patients...

Ogkologos - 15 Ιουνίου, 2023

What to Do If You’ve Been Diagnosed With Cancer in the...

Ogkologos - 13 Ιουνίου, 2023

Breast cancer mortality down 66% in 20 years

Ogkologos - 13 Ιουνίου, 2023

Adding Atezolizumab to Cabozantinib Fails to Improve Clinical Outcomes and Increases...

Ogkologos - 13 Ιουνίου, 2023

ASCO 2023 roundup: Blood tests, drugs and exercise

Ogkologos - 12 Ιουνίου, 2023

Clinical Benefit and Safety of Encorafenib Plus Binimetinib in Treatment-Naïve and...

Ogkologos - 12 Ιουνίου, 2023

Cancer in My Community: Caring for Children With Cancer in Paraguay

Ogkologos - 8 Ιουνίου, 2023

Blinatumomab Increases Survival for Infants with an Aggressive Type of ALL

Ogkologos - 8 Ιουνίου, 2023

Inequalities cause 2,000 extra cancer cases in Wales

Ogkologos - 8 Ιουνίου, 2023

Zanidatamab Demonstrates Meaningful Clinical Benefit with a Manageable Safety Profile in...

Ogkologos - 7 Ιουνίου, 2023

1...126127128...432 Σελίδα 127 από 432

MOST POPULAR

Adjuvant Pembrolizumab Continues to Demonstrate Benefit in DFS and OS Among...

3 Σεπτεμβρίου, 2026

We want every scientist to thrive in cancer research

28 Ιουλίου, 2023

Immunoscore Classification Significantly Associates with Time to Recurrance In Asian Patients...

21 Νοεμβρίου, 2020

A PET-based, pCR-adapted Chemotherapy De-escalation Strategy Associated with an Excellent 3-year...

5 Απριλίου, 2024

Φόρτωση περισσοτέρων

Concurrent Chemoradiotherapy Followed by Adjuvant Cisplatin-Gemcitabine for the Treatment of Patients...

What to Do If You’ve Been Diagnosed With Cancer in the...

Breast cancer mortality down 66% in 20 years

Adding Atezolizumab to Cabozantinib Fails to Improve Clinical Outcomes and Increases...

ASCO 2023 roundup: Blood tests, drugs and exercise

Clinical Benefit and Safety of Encorafenib Plus Binimetinib in Treatment-Naïve and...

Cancer in My Community: Caring for Children With Cancer in Paraguay

Blinatumomab Increases Survival for Infants with an Aggressive Type of ALL

Inequalities cause 2,000 extra cancer cases in Wales

Zanidatamab Demonstrates Meaningful Clinical Benefit with a Manageable Safety Profile in...

MOST POPULAR

Adjuvant Pembrolizumab Continues to Demonstrate Benefit in DFS and OS Among...

We want every scientist to thrive in cancer research

Immunoscore Classification Significantly Associates with Time to Recurrance In Asian Patients...

A PET-based, pCR-adapted Chemotherapy De-escalation Strategy Associated with an Excellent 3-year...

HOT NEWS

New on NCI’s Websites for March 2025

FDA Approves Durvalumab for Resectable Gastric or Gastro-Oesophageal Junction Adenocarcinoma

Cancer Immunotherapies Don’t Work for Everyone: HLA Gene May Explain Why

20 years on: how we’ve decreased cancer death rates

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ